REQUEST A DEMO
Total
USD $0.00
Search more companies

Ihl Lifesciences Private Limited (India)

Main Activities: Fertilizer Manufacturing
Full name: Ihl Lifesciences Private Limited Profile Updated: August 17, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

Ihl Lifesciences Private Limited is based in India, with the head office in Indore. The enterprise currently operates in the Fertilizer Manufacturing sector. Ihl Lifesciences Private Limited was incorporated on June 01, 2011. In 2025, the company reported a net sales revenue increase of 13.76%. During that time, Ihl Lifesciences Private Limited’s total assets grew by 35.7%. In, 2025, the company’s net profit margin increased by 4.62%.

Headquarters
Office No.836 C 8Th Floor Jhabua Tower Rnt Marg Indore Tukoganj Indore In-Mp In 452001
Indore; Madhya Pradesh; Postal Code: 452001

Contact Details: Purchase the Ihl Lifesciences Private Limited report to view the information.

Basic Information
Registered Capital:
Purchase the Ihl Lifesciences Private Limited report to view the information.
Financial Auditors:
Purchase the Ihl Lifesciences Private Limited report to view the information.
Incorporation Date:
June 01, 2011
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Ownership Details
Purchase this report to view the information.
50%
Purchase this report to view the information.
25%
Purchase this report to view the information.
25%
Company Performance
Financial values in the chart are available after Ihl Lifesciences Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
13.76%
Total Operating Revenue
13.74%
Operating Profit
122.75%
EBITDA
126.98%
Net Profit/Loss for the Period
132.09%
Total Assets
35.7%
Total Equity
214.22%
Operating Profit Margin
6.59%
Net Profit Margin
4.62%
Return on Equity (ROE)
-19.67%
Debt / Equity
-59.07%
Quick Ratio
0.56%
Cash Ratio
0.39%

Related EMIS Industry Reports

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?